Literature DB >> 33584620

CRISPR-Cas9-Based Toolkit for Clostridium botulinum Group II Spore and Sporulation Research.

Anna Mertaoja1, Maria B Nowakowska1, Gerald Mascher1, Viivi Heljanko1, Daphne Groothuis2, Nigel P Minton2, Miia Lindström1.   

Abstract

The spores of Clostridium botulinum Group II strains pose a significant threat to the safety of modern packaged foods due to the risk of their survival in pasteurization and their ability to germinate into neurotoxigenic cultures at refrigeration temperatures. Moreover, spores are the infectious agents in wound botulism, infant botulism, and intestinal toxemia in adults. The identification of factors that contribute to spore formation is, therefore, essential to the development of strategies to control related health risks. Accordingly, development of a straightforward and versatile gene manipulation tool and an efficient sporulation-promoting medium is pivotal. Our strategy was to employ CRISPR-Cas9 and homology-directed repair (HDR) to replace targeted genes with mutant alleles incorporating a unique 24-nt "bookmark" sequence that could act as a single guide RNA (sgRNA) target for Cas9. Following the generation of the sporulation mutant, the presence of the bookmark allowed rapid generation of a complemented strain, in which the mutant allele was replaced with a functional copy of the deleted gene using CRISPR-Cas9 and the requisite sgRNA. Then, we selected the most appropriate medium for sporulation studies in C. botulinum Group II strains by measuring the efficiency of spore formation in seven different media. The most effective medium was exploited to confirm the involvement of a candidate gene in the sporulation process. Using the devised sporulation medium, subsequent comparisons of the sporulation efficiency of the wild type (WT), mutant and "bookmark"-complemented strain allowed the assignment of any defective sporulation phenotype to the mutation made. As a strain generated by complementation with the WT gene in the original locus would be indistinguishable from the parental strain, the gene utilized in complementation studies was altered to contain a unique "watermark" through the introduction of silent nucleotide changes. The mutagenesis system and the devised sporulation medium provide a solid basis for gaining a deeper understanding of spore formation in C. botulinum, a prerequisite for the development of novel strategies for spore control and related food safety and public health risk management.
Copyright © 2021 Mertaoja, Nowakowska, Mascher, Heljanko, Groothuis, Minton and Lindström.

Entities:  

Keywords:  CRISPR-Cas9; Clostridium botulinum Group II; spo0A; spore; sporulation medium

Year:  2021        PMID: 33584620      PMCID: PMC7873358          DOI: 10.3389/fmicb.2021.617269

Source DB:  PubMed          Journal:  Front Microbiol        ISSN: 1664-302X            Impact factor:   5.640


  38 in total

1.  Codon usage tabulated from international DNA sequence databases: status for the year 2000.

Authors:  Y Nakamura; T Gojobori; T Ikemura
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Regulation of neurotoxin production and sporulation by a Putative agrBD signaling system in proteolytic Clostridium botulinum.

Authors:  Clare M Cooksley; Ian J Davis; Klaus Winzer; Weng C Chan; Michael W Peck; Nigel P Minton
Journal:  Appl Environ Microbiol       Date:  2010-05-07       Impact factor: 4.792

Review 3.  CRISPR Genome Editing Systems in the Genus Clostridium: a Timely Advancement.

Authors:  Kathleen N McAllister; Joseph A Sorg
Journal:  J Bacteriol       Date:  2019-07-24       Impact factor: 3.490

Review 4.  The Clostridium sporulation programs: diversity and preservation of endospore differentiation.

Authors:  Mohab A Al-Hinai; Shawn W Jones; Eleftherios T Papoutsakis
Journal:  Microbiol Mol Biol Rev       Date:  2015-03       Impact factor: 11.056

5.  Alternative sigma factor SigK has a role in stress tolerance of group I Clostridium botulinum strain ATCC 3502.

Authors:  Elias Dahlsten; David Kirk; Miia Lindström; Hannu Korkeala
Journal:  Appl Environ Microbiol       Date:  2013-04-05       Impact factor: 4.792

6.  Neurotoxin synthesis is positively regulated by the sporulation transcription factor Spo0A in Clostridium botulinum type E.

Authors:  Gerald Mascher; Anna Mertaoja; Hannu Korkeala; Miia Lindström
Journal:  Environ Microbiol       Date:  2017-09-15       Impact factor: 5.491

7.  The effect of recovery medium on the estimated heat-inactivation of spores of non-proteolytic Clostridium botulinum.

Authors:  M W Peck; D A Fairbairn; Barbara M Lund
Journal:  Lett Appl Microbiol       Date:  1992-10       Impact factor: 2.858

8.  Sporulation and Toxin Production by Clostridium botulinum Type G.

Authors:  H M Solomon; D A Kautter
Journal:  J Food Prot       Date:  1979-12       Impact factor: 2.077

9.  Hazard and control of group II (non-proteolytic) Clostridium botulinum in modern food processing.

Authors:  Miia Lindström; Katri Kiviniemi; Hannu Korkeala
Journal:  Int J Food Microbiol       Date:  2006-02-09       Impact factor: 5.277

10.  Generation of a fully erythromycin-sensitive strain of Clostridioides difficile using a novel CRISPR-Cas9 genome editing system.

Authors:  Patrick Ingle; Daphne Groothuis; Peter Rowe; He Huang; Alan Cockayne; Sarah A Kuehne; Weihong Jiang; Yang Gu; Christopher M Humphreys; Nigel P Minton
Journal:  Sci Rep       Date:  2019-05-31       Impact factor: 4.379

View more
  2 in total

1.  Sporulation Strategies and Potential Role of the Exosporium in Survival and Persistence of Clostridium botulinum.

Authors:  Inês M Portinha; François P Douillard; Hannu Korkeala; Miia Lindström
Journal:  Int J Mol Sci       Date:  2022-01-11       Impact factor: 5.923

2.  Construction and validation of safe Clostridium botulinum Group II surrogate strain producing inactive botulinum neurotoxin type E toxoid.

Authors:  Maria B Nowakowska; Katja Selby; Adina Przykopanski; Maren Krüger; Nadja Krez; Brigitte G Dorner; Martin B Dorner; Rongsheng Jin; Nigel P Minton; Andreas Rummel; Miia Lindström
Journal:  Sci Rep       Date:  2022-02-02       Impact factor: 4.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.